10.1101/gad.12.7.982 Summary Keywords animal models, pharmacological treatments, metabolic syndrome, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, steatosis Citation Peng C, Stewart AG, Woodman OL, Ritchie RH and Qin CX (2020) Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
HUBERMAN: Are the effects of certain peptides on metabolism and growth
4.1 Loss of gray matter, white matter, and hippocampal volume The loss of GM, WM, and hippocampal volume, as well as WMLs, is believed to underlie DM-associated cognitive dysfunction (100)
Rising levels of NAPQI in the liver cause widespread damage, including lipid peroxidation, inactivation of cellular proteins, and disruption of DNA metabolism (Bessems 2001)